-
Florida Hospital Association president Mary Mayhew tells "The Florida Roundup" that she hopes people can start benefitting from the program within the year.
-
Alex Azar advanced Canadian drug importation as Donald Trump’s secretary of Health and Human Services. Now he chairs the board of a company managing Florida’s importation program.
-
Health officials say a preliminary review finds no connection between suicidal thoughts and a new class of diabetes and obesity drugs, but they cannot definitively rule out “a small risk may exist."
-
Health Canada said “bulk importation will not provide an effective solution to the problem of high drug prices in the U.S." while noting it would ensure Canadians have access to the medications they need.”
-
The FDA said Florida’s program will be authorized for two years. Approval comes after months of wrangling that led to the state filing two lawsuits against the agency.
-
Dr. Joseph Ladapo again raised concerns about the delivery of "nucleic acid contaminants" in the vaccines and the "risk of DNA integration" into cells. And again, the FDA stood behind the science.
-
Thousands of fake units of the drug have been seized by the FDA, which is working alongside the manufacturer to test the counterfeit products for safety concerns.
-
The Food and Drug Administration is working with Ecuadorian authorities to investigate Negasmart, who has been supplying cinnamon to the three recalled applesauce brands.
-
AHCA Secretary Jason Weida told a state House panel he is “cautiously optimistic” the FDA will approve the plan, which the state has been pursuing since 2019.
-
Repeated recalls of eyedrops are drawing new attention to the limited powers U.S. regulators have to oversee medical products made overseas.